Washington · 2025–26 Regular Sessions · Bill
HB 1413: Opioid reversal purchasing
In committee Official data
- Introduced
- In committee
- Passed one chamber
- Passed both chambers
- Enacted
Last official action: ·Record last updated:
Plain-language summary
HB 1413 is a bill introduced in the Washington House on January 20, 2025. According to its official title, it concerns: Prohibiting government purchases of opioid overdose reversal medications from certain entities. Primary sponsor: Kristine Reeves (D). Most recent recorded action (January 12, 2026): By resolution, reintroduced and retained in present status.
Generated automatically from the official title, sponsor list, and status record only. It does not characterize the bill’s purpose or effects. How summaries are written
Official title
AN ACT Relating to prohibiting government purchases of opioid overdose reversal medications from certain entities;
Nonpartisan staff bill reports (analyses) are available on the official bill page.
Sponsors
Sponsors by party (alphabetical): Democratic 1
| Name | Role | Party | Chamber | District |
|---|---|---|---|---|
| Kristine Reeves | Primary sponsor | Democratic | House | 30 |
“Support” is shown only as formal sponsorship recorded by the legislature. Roll-call votes are available on the official bill page.
Recent official actions
- By resolution, reintroduced and retained in present status.
- First reading, referred to Health Care & Wellness.